BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,169,082 | -2.2% | 47,580 | -2.8% | 0.00% | 0.0% |
| Q2 2023 | $5,282,895 | -13.6% | 48,947 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $6,114,991 | -6.9% | 49,089 | +12.3% | 0.00% | 0.0% |
| Q4 2022 | $6,568,000 | +68.5% | 43,718 | +51.3% | 0.00% | +100.0% |
| Q3 2022 | $3,899,000 | -19.5% | 28,904 | -11.0% | 0.00% | -50.0% |
| Q2 2022 | $4,844,000 | -13.5% | 32,493 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $5,601,000 | -2.1% | 32,838 | +48.0% | 0.00% | 0.0% |
| Q4 2021 | $5,720,000 | +240.1% | 22,189 | +219.1% | 0.00% | +100.0% |
| Q3 2021 | $1,682,000 | +199.8% | 6,953 | +177.6% | 0.00% | – |
| Q2 2021 | $561,000 | -98.4% | 2,505 | -99.2% | 0.00% | -100.0% |
| Q1 2021 | $34,296,000 | +0.9% | 314,083 | -24.7% | 0.01% | -8.3% |
| Q4 2020 | $34,006,000 | -23.6% | 417,140 | -35.1% | 0.01% | -33.3% |
| Q3 2020 | $44,523,000 | – | 643,112 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |